My Drug Enforcement and Policy Center colleague at Ohio State, Jana Hrdinova, has made an annual tradition of writing up a spectacular report on Ohio’s experiences with its medical marijuana program and the views of patients and potential patients on the program. The latest edition of this report appears here at SSRN, and here is its abstract:
The seventh annual report traces the progress of the Ohio Medical Marijuana Control Program (OMMCP) since its inception in January 2019 to date, and it also discusses the first year of sales in Ohio’s recreational marijuana industry. In addition to providing state data about the medical and recreational cannabis industry in fiscal year 2025 (July 1, 2024 – June 30, 2025), the report also presents survey results focused on patients’ and other users’ satisfaction levels with the existing medical marijuana program, the impact of the beginning of recreational sales on the experience of Ohio’s patients and other users, patients’ willingness to continue to register as medical marijuana patients, and which policies would make it more likely for patients to stay engaged with the medical marijuana program. For the first time ever, we also surveyed participants on their use of delta-8 products and their perceptions of delta-8 product safety and availability. The final section concludes with several policy priorities for regulators’ and policymakers’ consideration.
The full report is a must read for anyone interested in understand marijuana reform realities in Ohio (and beyond). The report is full of interesting data and graphics, including this one her reporting on all the sources of revenue to Ohio from its legalization and regulation of now both medical and adult-use marijuana.
